Screener
Neuropace, Inc. NPCE Restricted Cash
Restricted Cash at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestrictedCashNoncurrent.
The source filing: Neuropace, Inc.’s 10-Q, filed August 11, 2026. Open the filing →
- Filed
- Aug 11, 2026, 4:33 PM EDT
- Fiscal quarter
- Q4 FY2030
- Calendar quarter
- Q4 2030
- Accession
- 0001528287-26-000030
FAQ
- What is Neuropace, Inc.'s restricted cash?
- Neuropace, Inc. (NPCE) reported restricted cash of $241K in Q2 2026.
- How has Neuropace, Inc.'s restricted cash changed year-over-year?
- Neuropace, Inc.'s restricted cash increased by 97.5% year-over-year, from $122K to $241K.
- What is the long-term trend for Neuropace, Inc.'s restricted cash?
- Over 5 years (2020 to 2025), Neuropace, Inc.'s restricted cash has grown at a -19.7% compound annual growth rate (CAGR), from $366K to $122K.
- What does restricted cash mean?
- Cash restricted for specific purposes by contractual, regulatory, or legal requirements — not available for general corporate use.
Ask your AI about Neuropace, Inc.'s restricted cash.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude